CommentCandida auris: a global fungal public health threat
References (13)
Fungal diseases: an evolving public health challenge
Med Mycol
(2006)Don't forget the fungi when considering global catastrophic biorisks
Health Secur
(2017)Meeting on global surveillance of antimicrobial resistance: invasive candida infections
- et al.
Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey
Lancet Infect Dis
(2018) - et al.
Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
PLoS Pathog
(2017) - et al.
New clonal strain of Candida auris, Delhi, India
Emerg Infect Dis
(2013)
There are more references available in the full text version of this article.
Cited by (67)
Synthesis of a unique mannose α-1-phosphate side chain moiety found in Candida auris cell wall mannan
2024, Carbohydrate ResearchLevels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study
2022, Clinical Microbiology and InfectionCitation Excerpt :Candida auris is an emerging health care-associated pathogen with significant morbidity and mortality [1].
Genetic relatedness among azole-resistant Candida tropicalis clinical strains in Taiwan from 2014 to 2018
2022, International Journal of Antimicrobial AgentsCitation Excerpt :However, we cannot rule out the possibility that another unknown human source is involved, such as has been reported for C. parapsilosis [27–30]. Although not generally airborne, like multidrug-resistant Candida auris causing outbreaks in healthcare settings [31], azole-resistant C. tropicalis may colonise humans through direct contact or through food and water in the community. In the present study, approximately two-thirds of patients infected or colonised by fluconazole-resistant C. tropicalis had not received azole antifungal agents prior to C. tropicalis isolation.
© 2018 Elsevier Ltd. All rights reserved.